Using AI-Powered Bioinformatics & Antigen Presenting Cells to Create a Measurable & Trackable Precision TIL Product Targeting Clonal Neoantigens

Time: 10:00 am
day: Day Two

Details:

• Discover using AI-powered bioinformatics and knowledge of cancer evolution to target clonal neoantigens

• Explore clonal antigens as the ideal solid-tumor targets

• Decipher potential potency assay benefits to a trackable, measurable product

Speakers: